About the HPTN

Mission Statement

The HPTN is dedicated to the discovery and development of new and innovative research strategies to reduce the acquisition and transmission of HIV.

The HIV Prevention Trials Network (HPTN) is a worldwide collaborative clinical trials network that brings together investigators, ethicists, community and other partners to develop and test the safety and efficacy of interventions designed to prevent the acquisition and transmission of HIV. HPTN studies evaluate new HIV prevention interventions and strategies in populations and geographical regions that bear a disproportionate burden of infection.

The HPTN research agenda is focused primarily on the use of integrated strategies: use of antiretroviral drugs (antiretroviral therapy and pre-exposure prophylaxis); interventions for substance abuse, particularly injection drug use; behavioral risk reduction interventions and structural interventions. The HPTN is committed to the highest ethical standards for its clinical trials and recognizes the importance of community engagement in all phases of the research process.

The HPTN was established in 2000, building on the work of the HIV Network for Prevention Trials (HIVNET). HPTN’s Leadership and Operations Center (LOC), is based at FHI 360, Durham, NC. Its Laboratory Center (LC) is at Johns Hopkins University, Baltimore, MD and its Statistical and Data Management Center (SDMC) is housed within the Statistical Center for HIV/AIDS Research and Prevention (SCHARP) at the Fred Hutchinson Cancer Research Center in Seattle, Washington.

HPTN receives its funding from three NIH institutes: the National Institute of Allergy and Infectious Diseases, the National Institute of Mental Health and the National Institute on Drug Abuse.

Fact Sheets

HPTN Fact Sheet

Webinars

The HPTN Leadership and Operations Center (LOC)

The HPTN Statistical and Data Management Center (SDMC)


Conversations with the HPTN

Theo Sandfort, Ph.D., is HPTN 075 protocol chair and professor of Clinical Sociomedical Sciences (in Psychiatry) at Columbia University and a research scientist at the New York State Psychiatric Institute.

Luciana Kamel is a community educator and counselor at Laboratory of Clinical Research (LaPClin)/Oswaldo Cruz Foundation (Fiocruz) in Rio de Janeiro, Brazil.

Mina Hosseinipour is HPTN 084 protocol co-chair and professor of medicine at the University of North Carolina (UNC) at Chapel Hill School of Medicine and the scientific director of UNC Project-Malawi in Lilongwe, Malawi.

Viet Anh Chu is the Research Manager at The University of North Carolina at Chapel Hill’s office in Vietnam. He manages HPTN 074 at Pho Yen CRS in Thai Nguyen, Vietnam and HPTN 083 at Yen Hoa CRS in Hanoi, Vietnam.